Skip to content
Search

Latest Stories

Community pharmacies can help reduce NHS backlog, says CCA

Skills and expertise of community pharmacies should be utilised to clear the NHS backlog as they can alleviate pressures within primary care systems, the Company Chemists Association (CCA) said in a statement.

Pharmacists can help free up GP capacity through the Community Pharmacist Consultation Service (CPCS) and increasing capacity for complex patients and beds through a Discharge Medications Service, it said.


Malcolm Harrison, chief executive officer of the CCA said that community pharmacies demonstrated an incredible effort during the Covid-19 pandemic by taking active part in the vaccination programme.

He said: “With access to fair and reasonable funding the sector was able to stand up and deliver 12 million Covid vaccinations to date as well as over 2 million flu vaccinations.

“To support the NHS organisations struggling under the pandemic fall-out, the health and social care system must continue to utilise the potential of community pharmacies going forward.”

While welcoming the Budget announcement to invest in the healthcare system, CCA highlighted the need for investment in the community pharmacy sector.

The association noted that by the end of 2024, funds available to pharmacies will have reduced in real-terms by around 25 per cent since 2014.

In absence of a long-term investment plan for the sector and innovation to build extra capacity, “we are concerned that pharmacy businesses will not be able to deliver the healthcare services that patients have become accustomed to during the Covid-19 pandemic nor will they alleviate pressures from other parts of the health system.”

Recently health secretary Sajid Javid urged all general practitioners in England to make full use of the GP CPCS referrals for minor illnesses “so our brilliant community pharmacists can do more in terms of prescribing”.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less